Vaccination Route Can Significantly Alter the Innate Lymphoid Cell Subsets: a Feedback Between IL-13 and IFN-γ

Overview

Journal NPJ Vaccines

Date 2018 Mar 22

PMID 29560282

Citations 17

Authors

Zheyi Li

Ronald J Jackson

Charani Ranasinghe

Affiliations

Soon will be listed here.

Abstract

This study demonstrates that the fate of a vaccine is influenced by the cytokines produced by the innate lymphoid cells (ILC) recruited to the vaccination site, and it is vaccine route and adjuvant dependent. Intranasal virus vaccination induced ST2/IL-33R ILC2 in lung, while intramuscular vaccination induced exclusively IL-25R ILC2 in muscle. Interestingly, a larger proportion of IL-13 ILC2s were detected in muscle following i.m. viral vector vaccination compared to lung post i.n. delivery. These observations revealed that ILC2 were the main source of IL-13 at the vaccination site (24 h post vaccination) responsible for inducing T cells of varying avidities. Moreover, recombinant fowlpox viral vector-based vaccines expressing adjuvants that transiently block IL-13 signalling at the vaccination site using different mechanisms (IL-4R antagonist or IL-13Rα2 adjuvants), revealed that the level of IL-13 present in the milieu also significantly influenced IFN-γ, IL-22 or IL-17A expression by ILC1/ILC3. Specifically, an early IL-13 and IFN-γ co-dependency at the ILC level may also be associated with shaping the downstream antibody responses, supporting the notion that differentially regulating IL-13 signalling via STAT6 or IL-13Rα2 pathways can modify ILC function and the resulting adaptive T- and B-cell immune outcomes reported previously. Moreover, unlike chronic inflammatory or experimentally induced conditions, viral vector vaccination induced uniquely different ILC profiles (i.e., expression of CD127 only on ILC2 not ILC1/ILC3; expression of IFN-γ in both NKP46 and NKp46 ILCs). Collectively, our data highlight that tailoring a vaccine vector/adjuvant to modulate the ILC cytokine profile according to the target pathogen, may help design more efficacious vaccines in the future.

Citing Articles

Location versus ID: what matters to lung-resident memory T cells?.

Macedo B, Masuda M, Borges da Silva H Front Immunol. 2024; 15:1355910.

PMID: 38375476 PMC: 10875077. DOI: 10.3389/fimmu.2024.1355910.

Mucosal immune responses to infection and vaccination in the respiratory tract.

Mettelman R, Allen E, Thomas P Immunity. 2022; 55(5):749-780.

PMID: 35545027 PMC: 9087965. DOI: 10.1016/j.immuni.2022.04.013.

Human Innate Lymphoid Cells in Influenza Infection and Vaccination.

Kumar A, Kumari R, Liu T, Cao W, Davidson B, Knight P Crit Rev Immunol. 2022; 41(3):57-82.

PMID: 35378011 PMC: 9185163. DOI: 10.1615/CritRevImmunol.2021040801.

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza.

Williams C, Roy S, Sun W, Furuya A, Wijesundara D, Furuya Y Clin Transl Immunology. 2022; 11(3):e1381.

PMID: 35356066 PMC: 8958247. DOI: 10.1002/cti2.1381.

IL-13Rα2 Regulates the IL-13/IFN-γ Balance during Innate Lymphoid Cell and Dendritic Cell Responses to Pox Viral Vector-Based Vaccination.

Li Z, Roy S, Ranasinghe C Vaccines (Basel). 2021; 9(5).

PMID: 34062727 PMC: 8147251. DOI: 10.3390/vaccines9050440.

References

Halim T, Hwang Y, Scanlon S, Zaghouani H, Garbi N, Fallon P . Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol. 2015; 17(1):57-64. PMC: 4685755. DOI: 10.1038/ni.3294. View

Spits H, Cupedo T . Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012; 30:647-75. DOI: 10.1146/annurev-immunol-020711-075053. View

Daines M, Khurana Hershey G . A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma. J Biol Chem. 2002; 277(12):10387-93. DOI: 10.1074/jbc.M108109200. View

Holmes C, Stanford W . Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells. 2007; 25(6):1339-47. DOI: 10.1634/stemcells.2006-0644. View

Ranasinghe C, Trivedi S, Wijesundara D, Jackson R . IL-4 and IL-13 receptors: Roles in immunity and powerful vaccine adjuvants. Cytokine Growth Factor Rev. 2014; 25(4):437-42. DOI: 10.1016/j.cytogfr.2014.07.010. View

Robinette M, Bando J, Song W, Ulland T, Gilfillan S, Colonna M . IL-15 sustains IL-7R-independent ILC2 and ILC3 development. Nat Commun. 2017; 8:14601. PMC: 5380969. DOI: 10.1038/ncomms14601. View

Almeida J, Price D, Papagno L, Arkoub Z, Sauce D, Bornstein E . Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J Exp Med. 2007; 204(10):2473-85. PMC: 2118466. DOI: 10.1084/jem.20070784. View

French M, Center R, Wilson K, Fleyfel I, Fernandez S, Schorcht A . Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers. AIDS. 2013; 27(4):519-28. DOI: 10.1097/QAD.0b013e32835cb720. View

Oliphant C, Hwang Y, Walker J, Salimi M, Wong S, Brewer J . MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity. 2014; 41(2):283-95. PMC: 4148706. DOI: 10.1016/j.immuni.2014.06.016. View

10.

Ravichandran J, Jackson R, Trivedi S, Ranasinghe C . IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization. J Interferon Cytokine Res. 2014; 35(3):176-85. PMC: 4350450. DOI: 10.1089/jir.2014.0078. View

11.

Serafini N, Vosshenrich C, Di Santo J . Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol. 2015; 15(7):415-28. DOI: 10.1038/nri3855. View

12.

Lim A, Menegatti S, Bustamante J, Le Bourhis L, Allez M, Rogge L . IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med. 2016; 213(4):569-83. PMC: 4821648. DOI: 10.1084/jem.20151750. View

13.

Moro K, Kabata H, Tanabe M, Koga S, Takeno N, Mochizuki M . Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol. 2015; 17(1):76-86. DOI: 10.1038/ni.3309. View

14.

Trivedi S, Jackson R, Ranasinghe C . Different HIV pox viral vector-based vaccines and adjuvants can induce unique antigen presenting cells that modulate CD8 T cell avidity. Virology. 2014; 468-470:479-489. DOI: 10.1016/j.virol.2014.09.004. View

15.

Huang Y, Guo L, Qiu J, Chen X, Hu-Li J, Siebenlist U . IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. Nat Immunol. 2014; 16(2):161-9. PMC: 4297567. DOI: 10.1038/ni.3078. View

16.

Spits H, Di Santo J . The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2010; 12(1):21-7. DOI: 10.1038/ni.1962. View

17.

Killig M, Glatzer T, Romagnani C . Recognition strategies of group 3 innate lymphoid cells. Front Immunol. 2014; 5:142. PMC: 3978353. DOI: 10.3389/fimmu.2014.00142. View

18.

Cupedo T, Crellin N, Papazian N, Rombouts E, Weijer K, Grogan J . Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol. 2008; 10(1):66-74. DOI: 10.1038/ni.1668. View

19.

Fichtner-Feigl S, Young C, Kitani A, Geissler E, Schlitt H, Strober W . IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology. 2008; 135(6):2003-13, 2013.e1-7. DOI: 10.1053/j.gastro.2008.08.055. View

20.

Kelly-Welch A, Hanson E, Boothby M, Keegan A . Interleukin-4 and interleukin-13 signaling connections maps. Science. 2003; 300(5625):1527-8. DOI: 10.1126/science.1085458. View